Work

Author response: Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages

Year: 2021

Type: peer-review

Abstract: As well as preventing bone loss, bisphosphonate drugs may boost early immune responses in the lung by acting directly on alveolar macrophages that form one of the first lines of defence against infection.

Source: eLife

DOI: 10.7554/elife.72430.sa2

Authors: Marcia A Munoz, Emma K Fletcher, Oliver P Skinner, Julie Jurczyluk, Esther Kristianto, Mark P Hodson, Shuting Sun, Frank H Ebetino, David R Croucher, Philip M Hansbro, Michael J Rogers

Institutions: Garvan Institute of Medical Research, UNSW Sydney, Victor Chang Cardiac Research Institute, The University of Queensland, University of Southern California, BioVinc (United States), University of Technology Sydney, Centenary Institute

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500

OpenAlex ID: W4200569160

Cites:

Cited by:

Related to: 10